Action RIGL RIGEL PHARMACEUTICALS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Rigel Pharmaceuticals, Inc.

Actions

RIGL

US7665596034

Marché Fermé - Nasdaq
Autres places de cotation
 22:00:00 31/05/2024 		Varia. 5j. Varia. 1 janv.
0,9778 USD +4,41 % Graphique intraday de Rigel Pharmaceuticals, Inc. +7,75 % -32,57 %
07/05 Transcript : Rigel Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 07, 2024
07/05 Rigel Pharmaceuticals, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Rigel to Present at the Jefferies Global Healthcare Conference
PR
Rigel: Q1 Earnings Snapshot
AQ
Rigel Announces Conference Call and Webcast to Report First Quarter 2024 Financial Results and Business Update
PR
Rigel Pharmaceuticals : March 2024
PU
Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
PR
Rigel Announces Publication of Data on REZLIDHIA in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia and Lymphoma
AQ
Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer
PR
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS
AQ
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update
PR
Rigel Pharmaceuticals Provides Business Update
AQ
Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
PR
Rigel Announces Collaboration with CONNECT to Conduct a Phase 2 Trial of Olutasidenib in Glioma
PR
Rigel to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PR
Rigel Pharmaceuticals and MD Anderson Announce Strategic Alliance to Advance REZLIDHIA in AML and Other Cancers
AQ
Rigel: Q3 Earnings Snapshot
AQ
Rigel to Present at the Jefferies London Healthcare Conference
PR
Rigel Announces Poster Presentations at the 65th American Society of Hematology Annual Meeting and Exposition
AQ
Rigel Announces Conference Call and Webcast to Report Third Quarter 2023 Financial Results and Business Update
PR
Rigel Announces Presentation at the Upcoming IDWeek 2023
PR
Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
PR
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action RIGL
  4. Actualités Rigel Pharmaceuticals, Inc.
  5. Communiqués
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT